Cargando…
In vitro inhibition of HUVECs by low dose methotrexate – insights into oral adverse events
BACKGROUND: With socio-economic changes, dentists and maxillofacial surgeons are more and more faced with medically compromised patients. Especially, the admission of antirheumatic drugs has increased remarkably. So dentists and maxillofacial surgeons should be aware of related adverse reactions tha...
Autores principales: | Annussek, Tobias, Szuwart, Thomas, Kleinheinz, Johannes, Koiky, Cathrin, Wermker, Kai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4033494/ https://www.ncbi.nlm.nih.gov/pubmed/24884884 http://dx.doi.org/10.1186/1746-160X-10-19 |
Ejemplares similares
-
Short time administration of antirheumatic drugs - Methotrexate as a strong inhibitor of osteoblast's proliferation in vitro
por: Annussek, Tobias, et al.
Publicado: (2012) -
Objective Assessment of Hypernasality in Patients with Cleft Lip and Palate with the NasalView System: A Clinical Validation Study
por: Wermker, Kai, et al.
Publicado: (2012) -
Nasopharyngeal Development in Patients with Cleft Lip and Palate: A Retrospective Case-Control Study
por: Wermker, Kai, et al.
Publicado: (2012) -
The impact of hyperbaric oxygen therapy on serological values of vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (bFGF)
por: Jung, Susanne, et al.
Publicado: (2010) -
Release kinetics of VEGF(165 )from a collagen matrix and structural matrix changes in a circulation model
por: Kleinheinz, Johannes, et al.
Publicado: (2010)